Health Products

MINT-Irbesartan/HCTZ Product Recall (2021-05-26)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

MINT-Irbesartan/HCTZ 150/12.5 mg Tablet

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
1805011402
Recalling Firm
Mint Pharmaceuticals Inc
6575 Davand Drive
Mississauga
L5T 2M3
Ontario
CANADA
Marketing Authorization Holder
Mint Pharmaceuticals Inc
6575 Davand Drive
Mississauga
L5T 2M3
Ontario
CANADA
B. MINT-Irbesartan/HCTZ 300/12.5 mg TabletDIN 02393018TabletIrbesartan 300 mg
1805011576
Recalling Firm
Mint Pharmaceuticals Inc
6575 Davand Drive
Mississauga
L5T 2M3
Ontario
CANADA
Marketing Authorization Holder
Mint Pharmaceuticals Inc
6575 Davand Drive
Mississauga
L5T 2M3
Ontario
CANADA
C. MINT-Irbesartan/HCTZ 300/25 mg TabletDIN 02393026TabletIrbesartan 300 mg
1805011398
Recalling Firm
Mint Pharmaceuticals Inc
6575 Davand Drive
Mississauga
L5T 2M3
Ontario
CANADA
Marketing Authorization Holder
Mint Pharmaceuticals Inc
6575 Davand Drive
Mississauga
L5T 2M3
Ontario
CANADA
A. MINT-Irbesartan/HCTZ 150/12.5 mg TabletDIN 02392992TabletIrbesartan 150 mg

Introduction

  1. MINT-Irbesartan/HCTZ 150/12.5 mg Tablet

  2. MINT-Irbesartan/HCTZ 300/12.5 mg Tablet

  3. MINT-Irbesartan/HCTZ 300/25 mg Tablet

Reason

Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.

Depth of distribution

Retailers, Wholesalers 

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime